Pharmaids Pharmaceuticals Ltd

NSE: PHARMAID · BSE: 524572 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹30.50
Market cap: ₹107.6 Cr
Revenue (annual): ₹27.88 Cr
Net profit (annual): ₹-11.72 Cr
P/E (TTM): -23.6×Sector 47.4×
Promoter holding: 32.99%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Other Announcement 2 Board Meeting Date 2 Annual General Meeting 2 Promoter Buying (Off-Market) 1 Management Change 1 Legal & Regulatory 1 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Jun 2026 19:16 IST BSE

Other Announcement

Pharmaids Pharmaceuticals Other Announcement

Pharmaids Pharmaceuticals appointed M/s. V Mahendra & Associates as internal auditors. The appointment is for the financial year 2026-27.

Execution: FY 2026-27

Read the filing ↗

8 May 2026 17:05 IST BSE

Other Announcement

Pharmaids Pharmaceuticals Other Announcement

Pharmaids Pharmaceuticals submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. This confirms the company's adherence to SEBI's regulatory disclosure standards.

Read the filing ↗